Iovance Biotherapeutics, Inc. (IOVA)

Iovance Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	171.67	115.69	114.89	231.73	78.23	67.33
Short-Term Investments	188.05	208.09	164.98	240.11	426.18	562.11
Cash & Short-Term Investments	359.71	323.78	279.87	471.85	504.41	629.44
Cash Growth	0.99%	15.69%	-40.69%	-6.46%	-19.86%	104.97%
Receivables	70.94	69.34	0.15	-	-	-
Inventory	65.55	51.52	10.37	-	-	-
Prepaid Expenses	15.89	12.38	17.46	7.27	3.55	6.66
Total Current Assets	512.65	457.02	307.85	479.12	507.96	636.1
Property, Plant & Equipment	162.49	164.28	176.55	178.25	169.92	113.92
Long-Term Investments	-	-	-	-	91.59	-
Other Intangible Assets	285.36	282.4	229.26	-	-	-
Other Long-Term Assets	6.25	6.73	66.7	6.62	7.87	18.44
Total Assets	966.74	910.43	780.35	663.98	777.33	768.46
Accounts Payable	28.49	27.51	33.12	26.6	27.38	13.51
Accrued Expenses	77.49	75.19	66.97	45.79	51.91	30.73
Current Portion of Leases	8.5	12.9	7.78	12.59	5.06	6.28
Other Current Liabilities	7.22	6.75	2.44	6.51	4.86	4.34
Total Current Liabilities	122.69	122.34	110.31	91.49	89.2	54.87
Long-Term Debt	-	1	1	1	1	-
Long-Term Leases	44.22	44.37	67.09	71.86	65.47	45.38
Long-Term Deferred Tax Liabilities	31.96	32.32	17.35	-	-	-
Other Long-Term Liabilities	-	-	-	-	-	11.71
Total Liabilities	198.88	200.02	195.74	164.34	155.67	111.96
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	3,262	3,096	2,594	2,069	1,795	1,487
Retained Earnings	-2,501	-2,385	-2,012	-1,568	-1,172	-830.19
Comprehensive Income & Other	6.29	-1.05	2.53	-0.9	-0.6	0.02
Total Common Equity	767.86	710.4	584.61	499.64	621.66	656.49
Shareholders' Equity	767.87	710.41	584.61	499.64	621.66	656.5
Total Liabilities & Equity	966.74	910.43	780.35	663.98	777.33	768.46
Total Debt	53.72	58.26	75.86	85.45	71.53	51.66
Net Cash (Debt)	305.99	265.52	204.01	386.4	432.88	577.78
Net Cash Growth	12.57%	30.15%	-47.20%	-10.74%	-25.08%	95.47%
Net Cash Per Share	1.01	0.92	0.87	2.43	2.82	4.18
Filing Date Shares Outstanding	333.93	327.88	279.31	224.24	157.17	146.98
Total Common Shares Outstanding	333.93	305.25	256.14	187.81	157	146.87
Working Capital	389.96	334.68	197.54	387.63	418.76	581.23
Book Value Per Share	2.30	2.33	2.28	2.66	3.96	4.47
Tangible Book Value	482.51	428	355.35	499.64	621.66	656.49
Tangible Book Value Per Share	1.44	1.40	1.39	2.66	3.96	4.47
Machinery	34.22	34.28	33.27	31.79	14.87	5.41
Construction In Progress	40.24	34.94	24.1	9.12	35.78	56.76
Leasehold Improvements	67.38	67.38	76.8	74.31	57.82	2.57

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q